HemoClear B.V.
PrivateLast Round
Early Funding
Jul 8, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
HemoClear B.V. is a medical device company that develops and manufactures innovative microfiltration technology for autologous blood transfusion.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HemoClear B.V. Comparables
Compare HemoClear B.V. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lindis Blood Care GmbH | 84% | |
| Sisu Global Health | 78% | |
| Medtronic | 76% | |
HemoClear B.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 8, 2024 | ||||
| Grant | Jun 13, 2020 |
Key People
Founding team and executive leadership
HemoClear B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EIT Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 74% MoM.
- Apr 16, 2026
Monthly visitors increased 221% MoM, reaching 3.1K.
HemoClear B.V. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HemoClear B.V.'s valuation, stock price, and market status.